|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/28 | |
| A61K 9/48 | |||
| A61K 47/48 | |||
| A61K 31/20 |
| (11) | Patento numeris | 2688558 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12760271.2 |
| Europos patento paraiškos padavimo data | 2012-03-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-01-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-10-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2012/002134 |
| Data | 2012-03-23 |
| (87) | Numeris | WO 2012/128587 |
| Data | 2012-09-27 |
| (30) | Numeris | Data | Šalis |
| 20110025940 | 2011-03-23 | KR | |
| 20110041168 | 2011-04-29 | KR |
| (72) |
KIM, Yong Il, KR
YOON, Eun Jin, KR
IM, Ho Taek, KR
SHIN, Yoon Sub, KR
PARK, Jae Hyun, KR
WOO, Jong Soo, KR
|
| (73) |
Hanmi Pharm. Co., Ltd.,
893-5 Hajeo-ri Paltan-myeon Hwaseong-si, Gyeonggi-do 445-910,
KR
|
| (54) | ORAL COMPLEX COMPOSITION COMPRISING OMEGA-3 FATTY ACID ESTER AND HMG-COA REDUCTASE INHIBITOR |
| ORAL COMPLEX COMPOSITION COMPRISING OMEGA-3 FATTY ACID ESTER AND HMG-COA REDUCTASE INHIBITOR |